Morphologic and molecular classification of lung neuroendocrine neoplasms Jasna Metovic et al, 2021, Virchows Archiv CrossRef
Neuroendocrine neoplasms of the lung: a pathology update Jasna Metovic et al, 2021, memo - Magazine of European Medical Oncology CrossRef
Clinical implications of lung neuroendocrine neoplasm classification Jasna Metovic et al, 2021, Expert Review of Anticancer Therapy CrossRef
Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors – Experiences from a tertiary referral center Barbara Kiesewetter et al, 2023, Journal of Neuroendocrinology CrossRef
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? Giuseppe Lamberti et al, 2018, International Journal of Molecular Sciences CrossRef
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids Ida Rapa et al, 2018, Oncotarget CrossRef
Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma Ying Zhang et al, 2022, BMC Cancer CrossRef
Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix Ran Zhu et al, 2019, Diagnostic Pathology CrossRef
Thoracic (Lung/Thymus) Neuroendocrine Neoplasms Marco Volante et al, 2021, The Spectrum of Neuroendocrine Neoplasia CrossRef
Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells Xiaokun Lin et al, 2018, Bioscience Reports CrossRef
Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing Andreas Mock et al, 2023, Scientific Reports CrossRef
Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
Marta Peri et al, 2020, Lung Cancer: Targets and Therapy CrossRef